SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending with significant buzz, driven by renewed analyst optimism and intense speculation around a potential short squeeze due to its high short interest. The community is keenly awaiting announcements from the ongoing J.P. Morgan Healthcare Conference, hoping for pivotal news on partnerships or strategic updates for its Matrix-M platform. This comes amidst strong calls for tangible execution from management as investor scrutiny intensifies.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is experiencing strong upward momentum following preliminary fourth-quarter revenue that significantly exceeded expectations, solidifying its role as a prominent defense drone manufacturer. The community is buzzing about the company's transition to a performance growth stock and eagerly awaits details on future contracts, particularly from the ongoing 'Drone Dominance Gauntlet' program. This positive sentiment is further amplified by broader market anticipation of increased defense spending and upcoming insights from the CEO's appearance at a major growth conference.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is captivating market attention amid escalating geopolitical tensions and recent CME margin adjustments, sparking intense debate on its future trajectory. Bulls confidently point to silver's strategic industrial demand and its role as a hedge against currency debasement, while a vocal bear contingent anticipates a significant pullback from its parabolic ascent. This strong conviction on both sides continues to drive extreme volatility and a notable short squeeze within the commodity.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is experiencing notable volatility and a price dip, igniting strong community debate around its immediate future. Many investors are seizing the "buy the dip" opportunity, emphasizing the company's robust fundamentals, zero debt, and strategic positioning in agentic AI, despite others citing recent CEO share sales and broader software sector weakness as driving factors. This sharp divergence in sentiment underscores high expectations for either a continued pullback or a significant upward reversal.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending as a major point of contention, with recent analyst downgrades intensifying concerns about its market position against a backdrop of increasing AI-powered competition. The community is sharply divided, debating whether the creative software giant is a deeply undervalued opportunity or facing significant headwinds from rivals like Apple and evolving AI solutions.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The iShares Russell 2000 ETF (IWM) is generating significant buzz, with many in the community celebrating its impressive breakout to new all-time highs as money rotates into small-cap stocks. This strong upward momentum is fueling discussions about whether small caps will continue to lead, particularly with upcoming economic data and the anticipated Supreme Court ruling on tariffs potentially influencing market sentiment.

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Travere Therapeutics Inc

Travere Therapeutics is experiencing extreme volatility following the FDA's request for additional data to characterize FILSPARI's clinical benefit for Focal Segmental Glomerulosclerosis (FSGS). The community is sharply divided, with many fearing a Complete Response Letter and significant further downside, while others view the substantial dip as an attractive buying opportunity, emphasizing the drug's strong efficacy and the critical unmet need for a first-in-class FSGS treatment.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan is trending after its Q4 earnings report, which, despite beating estimates, saw the stock react to concerns over a proposed credit card interest rate cap and a significant reserve build related to acquiring the Apple Card portfolio. Community discussion is split between those who view the cap as a substantial threat to bank profitability and others seeing the dip as a prime buying opportunity. Jamie Dimon's cautious economic outlook further fuels market debate around the financial sector's near-term direction.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant upward momentum driven by positive regulatory advancements for its seasonal flu and next-generation COVID-19 vaccine candidates, alongside promising results from a recent vaccine trial and new funding for a pivotal flu study. The community is actively discussing a potential short squeeze amidst high short interest, with many expressing renewed confidence in Moderna's diverse mRNA pipeline, particularly its oncology partnership.

Ambitions Enterprise Management Co. LLC operates as a travel agency. It provides event planning and management services. The firm also offers transportation, accommodations, meals, and guided tours or activities under convenient packages. The company was founded on October 26, 2023 and is headquartered in Dubai, United Arab Emirates.

Ambitions Enterprise Management Co LLC - Ordinary Shares - Class A

Ambitions Enterprise Management Co LLC

AHMA is experiencing significant momentum following recent news of its strong profitability and a new partnership for a major event/exhibition. The low-float, recent IPO status is amplifying volatility, leading many traders to aggressively target high price levels and anticipate a short squeeze, frequently drawing comparisons to past runners like SMX. However, some community members express skepticism, cautioning about its rapid ascent and the potential for a pump and dump.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vishwas Seshadri Sells 25,000 Shares of Abeona Therapeutics (NASDAQ:ABEO) Stock

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) CEO Vishwas Seshadri sold 25,000 shares of the stock in a transaction that occurred on Monday, December 29th. The shares were sold at an...

Abeona Therapeutics Inc. (NASDAQ:ABEO) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) have been given an average rating of "Moderate Buy" by the five analysts that are presently covering the stock, MarketBeat reports...

Abeona Therapeutics (NASDAQ:ABEO) CEO Vishwas Seshadri Sells 25,000 Shares

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) CEO Vishwas Seshadri sold 25,000 shares of the company's stock in a transaction on Monday, December 29th. The stock was sold at an average...

Boone Capital Management LLC Makes New Investment in Abeona Therapeutics Inc. $ABEO

Boone Capital Management LLC acquired a new stake in shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) during the second quarter, according to its most recent disclosure with the...

Abeona Therapeutics (NASDAQ:ABEO) Share Price Passes Below Two Hundred Day Moving Average - Time to Sell?

Abeona Therapeutics (NASDAQ:ABEO) Shares Pass Below 200-Day Moving Average - What's Next...

ABEO FY2025 EPS Forecast Lifted by Cantor Fitzgerald

Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) - Cantor Fitzgerald raised their FY2025 EPS estimates for Abeona Therapeutics in a report released on Tuesday, November 25th. Cantor Fitzgerald...

Mark Alvino Sells 15,000 Shares of Abeona Therapeutics (NASDAQ:ABEO) Stock

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) Director Mark Alvino sold 15,000 shares of the firm's stock in a transaction on Thursday, November 13th. The stock was sold at an average...

Abeona Therapeutics (NASDAQ:ABEO) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut Abeona Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...

Abeona Therapeutics (NASDAQ:ABEO) Director Mark Alvino Sells 15,000 Shares

Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) Director Mark Alvino sold 15,000 shares of the firm's stock in a transaction dated Thursday, November 13th. The stock was sold at an average...

Abeona Therapeutics (NASDAQ:ABEO) Posts Quarterly Earnings Results

Abeona Therapeutics (NASDAQ:ABEO - Get Free Report) announced its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($0.10) EPS for the quarter, topping analysts...

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Current Price	$5.12
Prev Close	$5.10
Open	$5.09
Dividend Yield	0.00%
50-Day Moving Average	$4.90
Beta	0.71
Avg. Volume	1.17M
PE Ratio	4.38

52-Week High	$7.54
52-Week Low	$3.93
Market Capitalization	$276.38M
EPS (Annual)	-$1.55
Price to Book	1.56
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

ABEO
Abeona Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABEO News

ABEOAbeona Therapeutics Inc